Mineralocorticoid excess may still be observed because these new compounds still inhibit both the CYP17A1-mediated hydroxylase and the 17,20-lyase reaction with similar IC50 values (cf. Table 1) although a recent patent application has suggested that compounds similar to 1 inhibit the lyase step35. This evidence concerns the gene CYP17A1 and Increased circulating aldosterone concentration.